Checkpoint Capital L.P. Quant / Systematic

Location: San Francisco, CA

CIK: 0001977548 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $196M (100.0% shares, 0.0% debt)

Holdings (16)

ARGX ARGENX SE 29.0%
Value $56.89M Shares 92,500 Est. Cost $400.24 Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 20.7%
Value $40.75M Shares 727,982 Est. Cost $35.60 Unrealized +55.1%
PHAT PHATHOM PHARMACEUTICALS INC 9.4%
Value $18.47M Shares 2,274,157 Est. Cost $11.69 Unrealized +5.9%
AXSM AXSOME THERAPEUTICS INC 7.5%
Value $14.79M Shares 174,769 Est. Cost $70.77 Unrealized +29.9%
IRON DISC MEDICINE INC 6.0%
Value $11.73M Shares 185,000 Est. Cost $56.34 Unrealized +2.7%
AVADEL PHARMACEUTICALS PLC 5.4%
Value $10.56M Shares 1,004,790 Est. Cost $14.06 Unrealized
RVMD REVOLUTION MEDICINES INC 4.7%
Value $9.185M Shares 210,000 Est. Cost $50.47 Unrealized 0.0%
PLRX PLIANT THERAPEUTICS INC 3.6%
Value $7.052M Shares 535,494 Est. Cost $13.01 Unrealized +5.0%
TCRX TSCAN THERAPEUTICS INC 2.7%
Value $5.338M Shares 1,755,987 Est. Cost $5.24 Unrealized -13.5%
CIDARA THERAPEUTICS INC 2.6%
Value $5.114M Shares 196,949 Est. Cost $12.75 Unrealized
TRVI TREVI THERAPEUTICS INC 2.3%
Value $4.467M Shares 1,084,135 Est. Cost $2.81 Unrealized +13.8%
STOK STOKE THERAPEUTICS INC 1.7%
Value $3.368M Shares 305,387 Est. Cost $13.25 Unrealized -7.3%
SLNO SOLENO THERAPEUTICS INC 1.6%
Value $3.148M Shares 70,027 Est. Cost $47.00 Unrealized +10.2%
KYMR KYMERA THERAPEUTICS INC 1.6%
Value $3.119M Shares 77,535 Est. Cost $45.17 Unrealized 0.0%
ATYR ATYR PHARMA INC 0.8%
Value $1.566M Shares 432,561 Est. Cost $1.40 Unrealized +116.3%
CYTK CYTOKINETICS INC 0.5%
Value $941K Shares 20,000 Est. Cost $47.79 Unrealized +8.7%